Quantitating Overall Neuropathic Symptoms, Impairments, and Outcomes
Authors:
- Peter J. DyckPDPeter J. Dyck
- Richard A.C. HughesRHRichard A.C. Hughes
- Peter C. O'BRienPOPeter C. O'BRien
- 1 January 2005
- book chapter
- Published by Elsevier
- p. 1031-1051
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic AcidDiabetes Care, 2003
- Long-term impact on work and private life after Guillain–Barré syndromeJournal of the Neurological Sciences, 2002
- Clinical versus quantitative vibration assessment: improving clinical performanceJournal of the Peripheral Nervous System, 2002
- Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic PolyneuropathyJAMA, 2000
- Total neuropathy scoreNeurology, 1999
- Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.Diabetes Care, 1999
- Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohortNeurology, 1997
- Development of a fatigue scaleJournal of Psychosomatic Research, 1993
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1989
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyNew England Journal of Medicine, 1986